source
- Ibrutinib Monotherapy Yields Decade-Long Durable Efficacy in Across CLL SubtypesIbrutinib monotherapy produced durable efficacy over 10 years in patients with or without TP53-mutated chronic lymphocytic leukemia.onclive · 2mo ago↗ source
- Imaging Clues That Raise Suspicion for Diffuse Midline Glioman this episode, Dr. Chong sets up the clinical reality that patients usually present with imaging before tissue and asks Dr. Shonka how MRI findings should shape suspicion for DMG.onclive · 2mo ago↗ source
- Two Diseases That Share a Name — Defining Glioblastoma and Diffuse Midline Glioma Under the 2021 WHO ClassificationIn this opening episode, Dr. Shonka and Dr. Chong frame the conversation around two diseases that share the name glioma but differ fundamentally in biology, demographics, and treatment.